Examines potential for precision medicine to be used in a genetic weapon system, state capabilities and motivations, and offers policy recommendations.
Women colleagues lead initiatives, publish innovative nonproliferation research, serve as mentors, and speak at conferences (or webinars, in the era of COVID-19).